High-Tech Technology Development Commercialization Fund

infomaster
Sep 2, 2021
1 min read

Celltium Inc. has been selected for the Korea Venture Investment High-Tech Technology Development Commercialization Fund and secured an investment of 1.5 billion won. This investment is planned to be used for the research and development of Charcot-Marie-Tooth disease treatment.

Recent Posts

See All

2022 SMEnterprise Technology Innovation Development Project

Celltium Corporation has been chosen to participate in the 'Market Expansion Type' of the 2022 Small and Medium Enterprise Technology...

Installation and Operation of Genetically Modified Organism Research Facilities

Celltium Corporation has received confirmation from the Ministry of Science and ICT for the installation and operation of genetically...

Completion of Animal Experiment Facility Registration

Celltium Corporation has established animal breeding management and animal experiment facilities within its corporate-affiliated research...

Comments